Member Feature

RION Completes Patient Enrollment for Innovative Diabetic Ulcer Study RION, a pioneering clinical-stage company focused on regenerative medicine, has reached a significant milestone by completing patient enrollment in its Phase 2 clinical trial for the Purified Exosome Product™ (PEP™). This innovative study aims to tackle the pressing problem of diabetic foot ulcers...

BrainsWay Leads in TMS Education Through Free CME Courses BURLINGTON, Mass. and JERUSALEM, Israel — BrainsWay, a leader in noninvasive neurostimulation treatments, is excited to announce its sponsorship of two free Continuing Medical Education (CME) courses. These courses aim to enhance mental health professionals' understanding and application of Transcranial Magnetic...

OCCIN Stock Hits New Heights In a notable market development, shares of OFS Credit Company (NASDAQ: OCCI) Inc. (OCCIN) have soared to an impressive 52-week high, reaching $23.52. This significant achievement reflects the steady upward trend of the investment firm, which primarily focuses on collateralized loan obligations. Over the last year, OCCIN's stock has shown...

Rapid Micro Biosystems to Report Fourth Quarter Financials Rapid Micro Biosystems, Inc. (NASDAQ: RPID), a pioneering force in life sciences technology, is gearing up to unveil its fourth quarter and full-year financial outcomes for 2024. This milestone is set to take place on February 28, 2025, before the stock market opens, reflecting the company's commitment to...

Update on Share Buyback Program The share buyback journey continues for Bekaert with exciting developments outlined in their latest announcement. Recently, a significant milestone was reached as the company initiated a new tranche of its share buyback program. The aim of this program is clear: to enhance shareholder value by reducing the total number of outstanding...